US Stock Details

Get in-depth insights on US stocks, including fundamentals, financials, shareholding, peer comparison, and performance. Track key metrics, price trends, and market sentiment for informed decisions. Stay ahead with expert analysis and data-driven strategies at Motilal Oswal.

Accuray Incorporated

us-stock
To Invest in {{usstockname}}
us-stock
$1.03 0(0%) ARAY at 04 Dec 2025 04:25 PM Medical Devices
Lowest Today 1.005
Highest Today 1.04
Today’s Open 1.02
Prev. Close 1.03
52 Week High 2.95
52 Week Low 0.91
Day’s Range: Low 1.005 High 1.04
52-Week Range: Low 0.91 High 2.95
1 day return -
1 Week return -5.99
1 month return -26.61
3 month return -32.22
6 month return -35.84
1 year return -49.87
3 year return -49.62
5 year return -76.33
10 year return -

Institutional Holdings

TCW Group Inc 10.57

BlackRock Inc 8.02

Vanguard Group Inc 4.77

Neuberger Berman Group LLC 4.66

Heartland Advisors Inc 4.49

Armistice Capital, LLC 2.87

Vanguard Total Stock Mkt Idx Inv 2.59

Renaissance Technologies Corp 2.31

Heartland Value Investor 2.22

iShares Russell 2000 ETF 2.16

Geode Capital Management, LLC 2.15

State Street Corp 1.77

Foundry Partners, LLC 1.59

D. E. Shaw & Co LP 1.59

UBS Group AG 1.58

Tenor Capital Management Co Lp 1.33

Neuberger Berman Intrinsic Value I 1.30

Harbert Fund Advisors Inc 1.29

Acuitas Investments, LLC 1.27

Dafna Capital Management LLC 1.08

North Star Investment Management Corp 1.06

Silverback Aset Management LLC 1.03

Mackenzie Investments 0.99

Vanguard Institutional Extnd Mkt Idx Tr 0.96

Kovack Advisors Inc 0.96

Fidelity Small Cap Index 0.89

North Star Micro Cap I 0.74

iShares Russell 2000 Growth ETF 0.71

Kennedy Extended Small Cap 0.64

Fidelity Enhanced Small Cap ETF 0.57

Fidelity Extended Market Index 0.49

Vanguard Russell 2000 ETF 0.43

Neuberger Berman Small Cap Intrinsic Val 0.43

Neuberger Berman US SCp Intrs Val $I Acc 0.43

Mackenzie US Small Cap F8 0.41

Column Small Cap Select 0.32

State St Russell Sm Cap® Indx SL Cl I 0.31

BlackRock Advantage Small Cap Core Instl 0.30

CREF Stock R3 0.25

AlphaCentric Robotics and Automation I 0.24

Market Status

Strong Buy: 3

Buy: 1

Hold: 0

Sell: 0

Strong Sell: 0

Fundamentals

Market Cap 116.74 M

PB Ratio 1.9786

PE Ratio 0.0

Enterprise Value 231.38 M

Total Assets 470.24 M

Volume 1877294

Company Financials

Annual Revenue FY25:458505000 458.5M, FY24:446551000 446.6M, FY23:447605000 447.6M, FY22:429909000 429.9M, FY21:396289000 396.3M

Annual Profit FY25:146967000 147.0M, FY24:142921000 142.9M, FY23:153960000 154.0M, FY22:159955000 160.0M, FY21:159507000 159.5M

Annual Net worth FY25:-1591000 -1.6M, FY24:-15545000 -15.5M, FY23:-9280000 -9.3M, FY22:-5347000 -5.3M, FY21:-6311000 -6.3M

Quarterly Revenue Q3/2025:93942000 93.9M, Q2/2025:127543000 127.5M, Q1/2025:113243000 113.2M, Q4/2024:116174000 116.2M, Q3/2024:101545000 101.5M

Quarterly Profit Q3/2025:26548000 26.5M, Q2/2025:38979000 39.0M, Q1/2025:31627000 31.6M, Q4/2024:41892000 41.9M, Q3/2024:34469000 34.5M

Quarterly Net worth Q3/2025:-21678000 -21.7M, Q2/2025:1123000 1.1M, Q1/2025:-1297000 -1.3M, Q4/2024:2537000 2.5M, Q3/2024:-3954000 -4.0M

Fund house & investment objective

Company Information Accuray Incorporated engages in the design, development, manufacture, and sale of radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Asia, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China. The company offers the CyberKnife platform, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, and prostate. It also provides the TomoTherapy platform, including the Radixact System, which allows for integrated radiation treatment planning, delivery, and data management, enabling clinicians to deliver ultra-precise treatments to approximately 50 patients per day; iDMS data management system, a fully integrated treatment planning and data management systems; and Accuray precision treatment planning system, a treatment planning and data management systems. In addition, the company offers post-contract customer support, installation, training, and other professional services. It primarily markets its products directly to customers, including hospitals and stand-alone treatment facilities through its sales organization, as well as to customers through sales agents and group purchasing organizations in the United States; and to customers directly and through distributors and sales agents internationally. Accuray Incorporated was incorporated in 1990 and is headquartered in Madison, Wisconsin.

Organisation Medical Devices

Employees 990

Industry Medical Devices

CEO Mr. Stephen R. LaNeve MBA

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right